Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of certain antiviral and antibacterial agents. Its trifluoromethyl group enhances metabolic stability and membrane permeability in drug molecules. The cyclopropylamine moiety contributes to binding selectivity in biological targets, making it valuable in medicinal chemistry for optimizing pharmacokinetic properties. Also employed in the preparation of kinase inhibitors and central nervous system-active compounds due to its ability to modulate lipophilicity and bioavailability.